Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2025	Dec. 31, 2024
Current assets:
Cash	$ 10,144,522	$ 9,601,298
Prepaid expenses and other current assets	816,260	473,834
Australia research and development incentives receivable	82,272	77,347
Total current assets	11,043,054	10,152,479
Other assets	2,800	2,800
Total assets	11,045,854	10,155,279
Current liabilities:
Accounts payable	1,723,163	1,512,436
Accrued expenses	3,320,789	2,317,602
Total current liabilities	5,043,952	3,830,038
Long term liabilities:
Warrant liability	2,125,218	2,690,605
Total liabilities	7,169,170	6,520,643
Commitments and contingencies (Note 7)
Stockholders’ equity (deficit)
Preferred stock, $0.0001 par value, 30,000,000 shares authorized at June 30, 2025 and December 31, 2024, 0 shares issued and outstanding
Common stock, $0.0001 par value, 150,000,000 shares and 70,000,000 shares authorized at June 30, 2025 and at December 31, 2024, respectively, 31,818,480 and 26,157,788 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively	3,182	2,616
Additional paid-in capital	101,002,585	90,897,468
Accumulated deficit	(97,099,055)	(87,234,833)
Accumulated other comprehensive loss	(30,028)	(30,615)
Total stockholders’ equity	3,876,684	3,634,636
Total liabilities and stockholders’ equity	$ 11,045,854	$ 10,155,279

Australia research and development incentives receivable.

No definition available.

Name:	MAIA_ResearchAndDevelopmentIncentivesReceivable
Namespace Prefix:	MAIA_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).